Follow along with a live blog as an FDA advisory panel discusses the first use of CRISPR genome editing in a treatment for sickle cell anemia.
Comments
(・_・;)
There's nothing here…
Follow along with a live blog as an FDA advisory panel discusses the first use of CRISPR genome editing in a treatment for sickle cell anemia.